Clinical impact and network of determinants of tumour necrosis in colorectal cancer.

Decreased serum apolipoprotein A1 levels are associated with poor survival and systemic inflammatory response in colorectal cancer. Sci Rep (2017) 0.75

Tumour invasiveness, the local and systemic environment and the basis of staging systems in colorectal cancer. Br J Cancer (2017) 0.75

Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res (2003) 103.76

Tumor angiogenesis and metastasis--correlation in invasive breast carcinoma. N Engl J Med (1991) 19.46

What is the evidence that tumors are angiogenesis dependent? J Natl Cancer Inst (1990) 13.41

REporting recommendations for tumour MARKer prognostic studies (REMARK). Br J Cancer (2005) 4.85

Worldwide variations in colorectal cancer. CA Cancer J Clin (2009) 4.71

An outcome prediction model for patients with clear cell renal cell carcinoma treated with radical nephrectomy based on tumor stage, size, grade and necrosis: the SSIGN score. J Urol (2002) 4.59

Immunohistochemical expression of endothelial markers CD31, CD34, von Willebrand factor, and Fli-1 in normal human tissues. J Histochem Cytochem (2005) 3.43

Selecting immunohistochemical cut-off scores for novel biomarkers of progression and survival in colorectal cancer. J Clin Pathol (2006) 2.17

Microvessel density and VEGF expression are prognostic factors in colorectal cancer. Meta-analysis of the literature. Br J Cancer (2006) 2.11

Colorectal serrated adenocarcinoma. Histopathology (2007) 2.04

Ki-67: level of evidence and methodological considerations for its role in the clinical management of breast cancer: analytical and critical review. Breast Cancer Res Treat (2011) 1.89

Prognostic value of thymidylate synthase, Ki-67, and p53 in patients with Dukes' B and C colon cancer: a National Cancer Institute-National Surgical Adjuvant Breast and Bowel Project collaborative study. J Clin Oncol (2003) 1.87

Stage-dependent alterations of the serum cytokine pattern in colorectal carcinoma. Br J Cancer (2012) 1.82

Patterns of morphologic alteration in residual rectal carcinoma following preoperative chemoradiation and their association with long-term outcome. Am J Surg Pathol (2004) 1.58

Tumor necrosis is a new promising prognostic factor in colorectal cancer. Hum Pathol (2010) 1.34

Prognostic value of tumour necrosis and host inflammatory responses in colorectal cancer. Br J Surg (2011) 1.33

Evaluation of microvascular density in tumors: pro and contra. Histol Histopathol (2008) 1.30

Detailed analysis of inflammatory cell infiltration in colorectal cancer. Br J Cancer (2013) 1.30

Assessment of invasive growth pattern and lymphocytic infiltration in colorectal cancer. Histopathology (1996) 1.28

TNM staging system of colorectal carcinoma: a critical appraisal of challenging issues. Arch Pathol Lab Med (2010) 1.24

Prognostic significance and molecular associations of tumor growth pattern in colorectal cancer. Ann Surg Oncol (2011) 1.16

Both high intratumoral microvessel density determined using CD105 antibody and elevated plasma levels of CD105 in colorectal cancer patients correlate with poor prognosis. Br J Cancer (2003) 1.14

Morphology and microsatellite instability in sporadic serrated and non-serrated colorectal cancer. J Pathol (2005) 1.13

Tumour necrosis is an independent prognostic marker in non-small cell lung cancer: correlation with biological variables. Lung Cancer (2002) 1.13

Ki-67 and coagulative tumor necrosis are independent predictors of poor outcome for patients with clear cell renal cell carcinoma and not surrogates for each other. Cancer (2007) 1.07

Tumor necrosis is associated with increased alphavbeta3 integrin expression and poor prognosis in nodular cutaneous melanomas. BMC Cancer (2008) 1.03

Identifying stage B colorectal cancer patients at high risk of tumor recurrence and death. Dis Colon Rectum (1997) 1.02

Frequent mutations of KRAS in addition to BRAF in colorectal serrated adenocarcinoma. Histopathology (2011) 1.00

Histologic tumor necrosis is an independent prognostic indicator for clear cell and papillary renal cell carcinoma. Am J Clin Pathol (2012) 0.98

The relationship between tumour necrosis, tumour proliferation, local and systemic inflammation, microvessel density and survival in patients undergoing potentially curative resection of oesophageal adenocarcinoma. Br J Cancer (2012) 0.94

Characteristics and significance of colorectal cancer associated lymphoid reaction. Int J Cancer (2013) 0.92

Endoglin (CD105) expression in angiogenesis of colon cancer: analysis using tissue microarrays and comparison with other endothelial markers. Virchows Arch (2005) 0.87

The in situ local immune response, tumour senescence and proliferation in colorectal cancer. Br J Cancer (2013) 0.87

Serum MMP-8 levels increase in colorectal cancer and correlate with disease course and inflammatory properties of primary tumors. Int J Cancer (2011) 0.83

A high peripheral microvessel density count correlates with a poor prognosis in pancreatic cancer. J Gastroenterol (2005) 0.83

The tumor border configuration of colorectal cancer as a histomorphological prognostic indicator. Front Oncol (2014) 0.83

Relationships of tumor inflammatory infiltration and necrosis with microsatellite instability in colorectal cancers. World J Gastroenterol (2005) 0.83

VE1 immunohistochemistry accurately detects BRAF V600E mutations in colorectal carcinoma and can be utilized in the detection of poorly differentiated colorectal serrated adenocarcinoma. Virchows Arch (2014) 0.82

Serum endostatin levels are elevated in colorectal cancer and correlate with invasion and systemic inflammatory markers. Br J Cancer (2014) 0.81

The relationships between serum cytokine levels and tumor infiltrating immune cells and their clinical significance in colorectal cancer. Int J Cancer (2016) 0.80